ATE320480T1 - Von der seebarsch epinephelus coioides derivierte unsterbliche zellinie und ihre verwendungen - Google Patents

Von der seebarsch epinephelus coioides derivierte unsterbliche zellinie und ihre verwendungen

Info

Publication number
ATE320480T1
ATE320480T1 AT99309705T AT99309705T ATE320480T1 AT E320480 T1 ATE320480 T1 AT E320480T1 AT 99309705 T AT99309705 T AT 99309705T AT 99309705 T AT99309705 T AT 99309705T AT E320480 T1 ATE320480 T1 AT E320480T1
Authority
AT
Austria
Prior art keywords
cell line
nnv
immortal cell
grouper
line derived
Prior art date
Application number
AT99309705T
Other languages
English (en)
Inventor
Shau-Chi Chi
Original Assignee
Nat Science Council Of The Rep
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Science Council Of The Rep filed Critical Nat Science Council Of The Rep
Application granted granted Critical
Publication of ATE320480T1 publication Critical patent/ATE320480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99309705T 1998-12-03 1999-12-02 Von der seebarsch epinephelus coioides derivierte unsterbliche zellinie und ihre verwendungen ATE320480T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11069998P 1998-12-03 1998-12-03

Publications (1)

Publication Number Publication Date
ATE320480T1 true ATE320480T1 (de) 2006-04-15

Family

ID=22334416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99309705T ATE320480T1 (de) 1998-12-03 1999-12-02 Von der seebarsch epinephelus coioides derivierte unsterbliche zellinie und ihre verwendungen

Country Status (5)

Country Link
US (2) US6436702B1 (de)
EP (1) EP1006178B1 (de)
AT (1) ATE320480T1 (de)
DE (1) DE69930357D1 (de)
TW (1) TWI220904B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050142A1 (en) * 2001-12-07 2003-06-19 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US7555017B2 (en) * 2002-12-17 2009-06-30 Tls Corporation Low latency digital audio over packet switched networks
TWI347364B (en) * 2003-02-19 2011-08-21 Novartis Ag Inactivated nodavirus vaccine
DE102005010288A1 (de) * 2005-03-02 2006-09-07 Riemser Arzneimittel Ag Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
CN101461941B (zh) 2007-12-20 2012-07-04 施怀哲维克有限公司 疫苗及其制备方法
CN101451122B (zh) * 2008-12-26 2012-11-28 中国海洋大学 褐点石斑鱼鳔细胞系的构建方法
CN102399743A (zh) * 2011-12-16 2012-04-04 中国水产科学研究院长江水产研究所 一种锦鲤鳍条组织细胞系及构建方法
AU2017215287A1 (en) * 2016-02-02 2018-08-16 Benchmark Animal Health Limited Methods of producing viruses
CN105925523B (zh) * 2016-04-29 2017-07-14 湖南农业大学 一种赤眼鳟鳍条细胞系及其建立方法与应用
CN111411073A (zh) * 2020-03-19 2020-07-14 华南农业大学 一种海鲈仔鱼细胞系的构建方法
CN113943693A (zh) * 2021-09-27 2022-01-18 广东海洋大学 一种罗非鱼腹鳍细胞系的构建方法
CN117143806B (zh) * 2023-10-18 2024-02-23 华南农业大学 一株斜带石斑鱼仔鱼细胞系及其构建方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135864A (en) 1983-09-15 1992-08-04 Institut Pasteur Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor
US5192539A (en) 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5236840A (en) 1990-01-18 1993-08-17 University Of Hawaii Method for growing crustacean virus in fish cells

Also Published As

Publication number Publication date
EP1006178B1 (de) 2006-03-15
US6566117B2 (en) 2003-05-20
US20020164787A1 (en) 2002-11-07
EP1006178A2 (de) 2000-06-07
US6436702B1 (en) 2002-08-20
DE69930357D1 (de) 2006-05-11
EP1006178A3 (de) 2003-05-21
TWI220904B (en) 2004-09-11

Similar Documents

Publication Publication Date Title
ATE320480T1 (de) Von der seebarsch epinephelus coioides derivierte unsterbliche zellinie und ihre verwendungen
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
EA200300023A1 (ru) 3'-ПРОЛЕКАРСТВА 2'-ДЕЗОКСИ-β-L-НУКЛЕОЗИДОВ
EA200300819A1 (ru) Производные нуклеозидов в качестве ингибиторов рнк-зависимой рнк вирусной полимеразы
PE10399A1 (es) Derivados de aminoacidos
DK0935660T3 (da) Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
EA200400886A1 (ru) Макроциклические пептиды, обладающие активностью в отношении вируса гепатита c
CO5160294A1 (es) Composicion farmaceutica que inhibe o detiene el crecimiento de virus en animales particularmente mamiferos sarrollo de virus en animales y composiciones farmaceuticas que los contienen
DK0702085T4 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
CO5271690A1 (es) Derivados de pirimidina
SG156673A1 (en) Improved viral purification methods
EA200100229A1 (ru) Пептидные ингибиторы вируса гепатита с
NO20070194L (no) Fremgangsmater for behandling av hepatitt C
DE3486160T2 (de) Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben.
HK1009980A1 (en) Method for selective inactivation of viral replication
BR0305259A (pt) Inibidores de hcv ns5b polimerase
DK1035203T3 (da) Cellekultur-tilpassede, genetisk manipulerede mutanter af infektiös bursalsyge-virus (IBDV)
EP1399163A4 (de) Verbindungen, verfahren und zusammensetzungen für die behandlung von infektionen mit dem rinderdiarrhö-virus (bvdv) und dem hepatitis-c-virus (hcv)
DE3485873T2 (de) Herpes simplex virus subunitimpfstoff.
AR019250A1 (es) Formas atenuadas del virus de la diarrea viral bovina, molecula de acido nucleico, vector, uso, metodo para modificar el genoma viral de tipo salvaje, genoma modificado, vacuna, metodo para atenuar un virus bvd de tipo salvaje
EA200300215A1 (ru) Вакцинация против вирусов герпеса, ассоциированных с хозяйской клеткой
NO970158L (no) Difluorstaton-antivirale midler
DK1187631T3 (da) Forebyggelse af type 1 diabetes og andre ikke-polio-enterovirus-sygdomme
DK8789D0 (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties